FDA Approves First Nasal Spray for Treatment of Anaphylaxis
Today, the U.S. Food and Drug Administration approved neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type I), including those that are life-threatening...
FDA Approves Second Over-the-Counter Naloxone Nasal Spray …
Today, the U.S. Food and Drug Administration approved RiVive, 3 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription use for the emergency treatment...
FDA Approves Spravato Nasal Spray for Treatment-Resistant …
4 days ago · WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...
SPRAVATO® (esketamine) approved in the U.S. as the first and …
5 days ago · Titusville, New Jersey, January 21, 2025 – Johnson & Johnson (NYSE: JNJ) announced today the U.S. Food and Drug Administration (FDA) approval of a supplemental New Drug Application (sNDA) for SPRAVATO ® (esketamine) CIII nasal spray, making this innovative treatment the first and only monotherapy for adults living with major depressive disorder (MDD) who have had an inadequate response to ...
FDA approves first nasal spray to treat dangerous allergic reactions
Aug 11, 2024 · The Food and Drug Administration said it approved the spray from drugmaker ARS Pharmaceuticals Inc. as an emergency treatment for adults and older children experiencing life-threatening allergic reactions known as anaphylaxis.
FDA Approves First Over-the-Counter Naloxone Nasal Spray
Today, the U.S. Food and Drug Administration approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription, use – the first naloxone...
FDA Approves First Nasal Spray for Treatment of Anaphylaxis - PR …
SILVER SPRING, Md., Aug. 9, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type...
FDA approves nasal spray as first needle-free treatment for …
The Food and Drug Administration has approved ARS Pharmaceuticals’ nasal spray as the first needle-free emergency treatment for potentially fatal allergic reactions, the agency said on Friday.
Neffy: First nasal spray epinephrine drug for emergency allergic ...
Aug 9, 2024 · The US Food and Drug Administration approved the first nasal spray epinephrine drug for severe allergic reactions known as anaphylaxis, providing a needle-free alternative to EpiPens...
FDA Approves First Nasal Spray, Neffy, to Curb Anaphylaxis, An ...
Aug 9, 2024 · The U.S. Food and Drug Administration on Friday announced that it has approved neffy, the first non-injected treatment for life-threatening allergic reactions. The epinephrine nasal spray is for use by adults and children who weigh more than 66 pounds, the agency said.